Asuragen launches mRNA analysis tool

Published: 2-Aug-2007

Asuragen, a molecular biology service provider and oncology molecular diagnostic company, has launched a high-content microRNA (miRNA) service.


Asuragen, a molecular biology service provider and oncology molecular diagnostic company, has launched a high-content microRNA (miRNA) service.

The service enables comprehensive analysis of miRNA expression profiles from published miRNA sequences and anexpanded set of unpublished candidate miRNAs.

The first generation platform for Asuragen's DiscovArraySM miRNA Expression Service uses a new Ambion array that is custom-manufactured by Affymetrix and designed specifically for miRNA expression analysis. Currently available only through Asuragen Services, the array contains features representing validated Sanger miRBase content in combination with over 12,000 exploratory human miRNAs.

The robustness of the Affymetrix platform and Asuragen's highly sensitive labeling technology combined with miRInform, a new web-enabled data delivery system from Asuragen, offer accurate data quality and value to anyone studying miRNAs.

You may also like